Quantitation and modeling of post-translational modifications in a therapeutic monoclonal antibody from single- and multiple-dose monkey pharmacokinetic studies using mass spectrometry-Reference-Cited by-同舟云学术

Quantitation and modeling of post-translational modifications in a therapeutic monoclonal antibody from single- and multiple-dose monkey pharmacokinetic studies using mass spectrometry

Published:2019-10-16 Issue:10 Volume:14 Page:e0223899
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Xu Xiaobin^ORCID,Huang Yu,Pan Hao,Molden Rosalynn,Qiu Haibo,Daly Thomas J.,Li Ning

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Current and future issues in the manufacturing and development of monoclonal antibodies;S Kozlowski;Advanced drug delivery reviews,2006

2. Heterogeneity of monoclonal antibodies;H Liu;Journal of pharmaceutical sciences,2008

3. Assessing monoclonal antibody product quality attribute criticality through clinical studies;AM Goetze;mAbs,2010

4. Antibody structure, instability, and formulation;W Wang;Journal of pharmaceutical sciences,2007

5. LC-MS multi-attribute method for characterization of biologics;X Xu;Journal of Applied Bioanalysis,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization and Antiatherogenic Potential of P3R99 Monoclonal Antibody Against Sulfated Glycosaminoglycans: Physicochemical and Functional Insights;2024-09-10

2. Mass spectrometry characterization of antibodies at the intact and subunit levels: From targeted to large-scale analysis;International Journal of Mass Spectrometry;2023-10

3. Molecular prediction of clinical response to anti‐PD ‐1/ anti‐PD‐L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry‐based investigations;International Journal of Cancer;2022-11-30

4. Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin® Biosimilar Candidate and Its Innovator: A Comparative Study;Pharmaceutics;2022-07-28

5. Identification, Efficacy, and Stability Evaluation of Succinimide Modification With a High Abundance in the Framework Region of Golimumab;Frontiers in Chemistry;2022-04-05